| Literature DB >> 26560355 |
Ryan Hohman1, Michael Shea1, Marina Kozak1, Samantha Roberts1, Jeff Allen1, Ellen Sigal2.
Abstract
As patient input in drug development increases and new data sources are tapped, regulators need to organize and ensure the quality of data to inform decision-making.Entities:
Mesh：
Year: 2015 PMID： 26560355 DOI： 10.1126/scitranslmed.aad5233
Source DB: PubMed Journal: Sci Transl Med ISSN： 1946-6234 Impact factor: 17.956